Finance

Lists
Why is TATVA up 2.18%?
Dive Deeper
TATVA:NSE
Tatva Chintan Pharma Chem Ltd
₹1,650.00
+2.18%
(+35.20) 1D
Oct 30, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for TATVA...
Open
₹1,624.90
High
₹1,659.00
Low
₹1,582.10
Mkt. cap
38.55B
Avg. vol.
135.06K
Volume
74.35K
Dividend
0.12%
Quarterly dividend
₹0.50
Ex-dividend date
Sep 11, 2026
P/E ratio
61.34
52-wk high
₹2,113.60
52-wk low
₹1,044.10
EPS
₹26.90
No. of employees
793
Open
₹1,624.90
High
₹1,659.00
Low
₹1,582.10
Mkt. cap
38.55B
Avg. vol.
135.06K
Volume
74.35K
Dividend
0.12%
Quarterly dividend
₹0.50
Ex-dividend date
Sep 11, 2026
P/E ratio
61.34
52-wk high
₹2,113.60
52-wk low
₹1,044.10
EPS
₹26.90
No. of employees
793
News stories
From web sources and news partners
About Tatva Chintan Pharma Chem Ltd
CEO-
Employees793
Founded1996
Headquarters-
SectorSpeciality chemicals
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.31B
1.34B
1.67B
2.17B
Cost of goods sold
551.45M
667.56M
752.91M
1.06B
Cost of revenue
551.45M
667.56M
752.91M
1.06B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
168.24M
187.87M
167.36M
182.29M
Operating expense
597.72M
462.20M
700.34M
811.73M
Total operating expenses
1.15B
1.13B
1.45B
1.87B
Operating income
164.17M
211.68M
217.30M
298.95M
Other non operating income
17.34M
-32.86M
27.80M
17.54M
EBT including unusual items
176.58M
168.48M
211.11M
289.40M
EBT excluding unusual items
176.58M
168.77M
224.29M
289.40M
Income tax expense
24.93M
65.27M
51.30M
74.89M
Effective tax rate
14.12%
38.74%
24.30%
25.88%
Other operating expenses
338.80M
176.78M
427.32M
521.50M
Net income
151.65M
103.21M
159.81M
214.51M
Net profit margin
11.55%
7.69%
9.57%
9.87%
Earnings per share
6.49
4.41
7.26
9.17
Interest and investment income
-
4.52M
-
-
Interest expense
-4.93M
-12.05M
-20.81M
-27.09M
Net interest expenses
-4.93M
-7.53M
-20.81M
-27.09M
Depreciation and amortization charges
90.68M
97.55M
105.66M
107.94M
EBITDA
230.48M
299.82M
309.42M
405.75M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps